Careers Denmark
Se alle job

Research & Development

Head of Translational Medicine and Early Development

LEO Pharma Ballerup, Denmark, Denmark, 2750 Publiceret 6. nov. 2026 Frist 22. nov. · 5 dage tilbage LEO Pharma CareersFastansættelseChef / direktør

Resumé

Leads Translational Medicine & Early Development, building early-development capabilities and decision-ready programs. The role integrates scientific, clinical, quantitative and external-partner expertise to guide proof-of-concept and development decisions.

Felterne er læst af AI fra opslaget. Har arbejdsgiveren selv udfyldt et felt, bruger vi det.

Kort om jobbet

Employment type: Permanent. Requisition: 4988. Country: Denmark.

Application deadline: November 22th, 2026

Location: Ballerup 2750, Denmark, Denmark

Contract type: Permanent

Job ID: 4988

Turn scientific promise into clinical progress. Build the proof-of-concept engine that helps LEO Pharma make smarter development decisions and bring meaningful innovation closer to patients.

Shape what comes next

How would you connect emerging biology, quantitative insights, and clinical expertise to shape the next generation of development programs? At LEO Pharma, you will lead Translational Medicine & Early Development, bringing together people, partners, and evidence to answer critical questions early.

This is an opportunity to build capabilities, influence portfolio decisions, and connect scientific ambition with a clear path to clinical proof of concept.

Your role

You will build and lead an integrated proof-of-concept engine, translating biological hypotheses into clinically testable, quantitatively informed, decision-ready programs. Working across internal teams and external partners, you will establish mechanism-based rationales, meaningful patient strategies, and robust development plans.

Your focus will be on generating the evidence needed to select doses, assess benefit–risk, and guide progression toward registrational studies.

Your primary responsibilities will be to

  • Lead translational and early-development strategy across programs, developing people leaders and subject-matter experts.
  • Partner with Science, Search & Innovation and clinical teams to design early-phase studies demonstrating target engagement, proof of mechanism, and patient relevance.
  • Integrate biomarkers, patient stratification, quantitative pharmacology, and modelling and simulation to optimize doses, regimens, endpoints, and study designs.
  • Support clinical due diligence and integration of externally sourced assets, building partnerships that strengthen translational capabilities.

Dette er et uddrag. Læs hele opslaget hos LEO Pharma Careers